Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Revisiting Early Stages of Chronic Myeloid Leukemia (CML): Evidence That Leukemic Progenitors Appear First in Peripheral Blood during Molecular Recurrence

Ali G Turhan, MD PhD, Patricia Hugues, Nathalie Sorel, Christophe Desterke, Annelise Bennaceur-Griscelli, MD PhD, Jean-Claude Chomel, PharmD PhD

Blood (2018) 132 (Supplement 1): 5425.

https://doi.org/10.1182/blood-2018-99-110676

Published: 2018

Journal Articles

Micro-RNA Profiling Reveals the Key Role of miR-206 in the Hematopoietic Potential of Human Embryonic and Induced Pluripotent Stem Cells

Stephane Flamant, Jean-Claude Chomel, PharmD PhD, Christophe Desterke, Olivier Feraud, Emilie Gobbo, Maria Teresa Mitjavila-Garcia, Adlen Foudi, Frank Griscelli, Ali G Turhan, MD PhD, Annelise Bennaceur-Griscelli, MD PhD

Blood (2018) 132 (Supplement 1): 1275.

https://doi.org/10.1182/blood-2018-99-110729

Published: 2018

Journal Articles

Prediction of One-Year Molecular Response to Imatinib at Diagnosis of Chronic Myeloid Leukemia By Scoring Gene Expression Levels of Antioxidant Enzymes

Frederic Picou, PhD, Jean-Claude Chomel, PharmD PhD, Marie Christine Bene, PharmD, Marc G. Berger, MD PhD, Thierry Fest, Valerie Ugo, MD PhD, Eric Lippert, MD PhD, Marion Socco-Luca, Martine Delain, MD, Marie-Helene Estienne, PharmD, Olivier Herault, MD PhD

Blood (2018) 132 (Supplement 1): 3024.

https://doi.org/10.1182/blood-2018-99-118297

Published: 2018

Journal Articles

ETS1 Expression Is Upregulated in Chronic Myeloid Leukemia (CML) and the ETS1 Transcriptional Program Correlates with Disease Progression Towards Blast Crisis

Christophe Desterke, PhD, Maud Voldoire, MD, Nathalie Sorel, Marie Laure Bonnet, Sarah Pagliaro, PharmD, Annelise Bennaceur-Griscelli, MD PhD, Emilie Cayssials, MD, Jean-Claude Chomel, PharmD PhD, Ali G Turhan, MD, PhD

Blood (2016) 128 (22): 442.

https://doi.org/10.1182/blood.V128.22.442.442

Published: 2016

Journal Articles

The Cell Surface NADH Oxidase ENOX2 Is Highly Expressed in Chronic Myeloid Leukemia (CML): a Redox Protein As a Secreted Surrogate Biomarker and Druggable Target

Seda Baykal, Maud Voldoire, MD, Christophe Desterke, Nathalie Sorel, Hyacinthe Atchroue Johnson Ansah, Agnes Guerci-Bresler, MD, Jean-Claude Chomel, PharmD PhD, Annelise Bennaceur-Griscelli, MD PhD, Ali G Turhan, MD, PhD

Blood (2016) 128 (22): 3059.

https://doi.org/10.1182/blood.V128.22.3059.3059

Published: 2016

Journal Articles

Combination of Dasatinib and Peg-Interferon Alpha 2b in Chronic Phase Chronic Myeloid Leukemia (CP-CML) First Line: Preliminary Results of a Phase II Trial, from the French Intergroup of CML (Fi-LMC)

Blood (2015) 126 (23): 134.

https://doi.org/10.1182/blood.V126.23.134.134

Published: 2015

Journal Articles

A Novel DNA Repair Chip Assay Allows Rapid Identification of DNA Repair Abnormalities Induced By BCR-ABL

Ali G Turhan, MD PhD, Fanny Sarrazy, Marie Laure Bonnet, Angelina Bertrand, Marie Claude Meunier, Djamel Aggoune, Jean-Claude Chomel, PharmD, PhD, Olivier Feraud, Sylvain Caillat, Annelise Bennaceur-Griscelli, MD PhD, Sylvie Sauvaigo, PhD

Blood (2014) 124 (21): 4536.

https://doi.org/10.1182/blood.V124.21.4536.4536

Published: 2014

Journal Articles

Superoxide Dismutase 2 (Sod2) Expression Is Highly Decreased In Chronic Myeloid Leukemia (CML): Contribution To Genetic Instability In Bcr-Abl-Expressing Leukemic Cells

Sandrine Girerd, Lucie Tosca, PharmD, PhD, Olivier Herault, MD, PhD, Christine Vignon, PhD, Denis Biard, PhD, Fatima Dkhissi, PhD, Clémentine Bouneau, Djamel Aggoune, Angelina Bertrand, Marie Laure Bonnet, Nathalie Sorel, PhD, Gerard Tachdjian, MD, PhD, François Guilhot, MD, Joelle Guilhot, PhD, Jean-Claude Chomel, PharmD, PhD, Ali G Turhan, MD, PhD

Blood (2013) 122 (21): 3980.

https://doi.org/10.1182/blood.V122.21.3980.3980

Published: 2013

Journal Articles

Interferon-Inducible Protein 16 (IFI-16) Is Upregulated In Chronic Myeloid Leukemia (CML) and Is Involved In Oncogene-Induced Senescence

Clémentine Bouneau, Marie Laure Bonnet, Marie Claude Meunier, Djamel Aggoune, Fatima Dkhissi, PhD, François Guilhot, MD, Annelise Bennaceur-Griscelli, MD, PhD, Jean-Claude Chomel, PharmD, PhD, Ali G Turhan, MD, PhD

Blood (2013) 122 (21): 2708.

https://doi.org/10.1182/blood.V122.21.2708.2708

Published: 2013

Journal Articles

BRCA1-Down-Regulation In Chronic Myeloid Leukemia (CML) Occurs Via The Deubiquitinase / Tumor Suppressor BRCA1-Associated Protein 1 (BAP1)

Fatima Dkhissi, PhD, Djamel Aggoune, Julien Pontis, Marie Laure Bonnet, Marie Claude Meunier, Nathalie Sorel, PhD, Clémentine Bouneau, Annelise Bennaceur-Griscelli, MD, PhD, François Guilhot, MD, Jean-Claude Chomel, PharmD, PhD, Slimane Ait-Si-Ali, PhD, Ali G Turhan, MD, PhD

Blood (2013) 122 (21): 3813.

https://doi.org/10.1182/blood.V122.21.3813.3813

Published: 2013

Journal Articles

T315I-Mutated BCR-ABL Induces a Distinct and Specific Molecular Signature With High Expression Of Zinc Finger (ZNF) Transcription Factors

Christophe Desterke, PhD, Djamel Aggoune, Marie Laure Bonnet, Nais Prade, Jean-Claude Chomel, PharmD, PhD, Eric Delabesse, MD, PhD, Ali G Turhan, MD, PhD

Blood (2013) 122 (21): 4899.

https://doi.org/10.1182/blood.V122.21.4899.4899

Published: 2013

Journal Articles

Sequential Measurement Of JAK2 V617F Allele Burden In Polycythemia Vera and Essential Thrombocythemia Reveals Different Evolution Profiles: First Results Of Jaksuivi, a Multicentre Study By The French Intergroup Of Myeloproliferative Neoplasms (FIM)

Caroline Buors, Françoise Boyer, Aline Tanguy-Schmidt, Aurélie Chauveau, Lydia Roy, MD, Jean-Claude Chomel, PharmD, PhD, Thierry Lamy, MD, PhD, Olivier Fardel, Olivier Herault, MD, PhD, Laura Samaison, Valérie Ugo, MD, PhD, Jean-Christophe Ianotto, MD

Blood (2013) 122 (21): 1593.

https://doi.org/10.1182/blood.V122.21.1593.1593

Published: 2013

Journal Articles

Evaluation of Leukemic Stem Cell Persistence in Chronic Myeloid Leukemia (CML) Patients in Complete Molecular Remission Induced by First Line TKI Therapies

Jean-Claude Chomel, PharmD, PhD, Marie Laure Bonnet, Nathalie Sorel, PhD, Ivan Sloma, PharmD, PhD, Alexis Proust, Annelise Bennaceur-Griscelli, MD, PhD, Delphine Rea, MD, PhD, Madalina Uzunov, M.D., Laurence Legros, MD, PhD, Shanti Ame, MD, Anne Marfaing-Koka, Agnès Guerci, MD, Philippe Rousselot, MD, PhD, Ali G Turhan, M.D., PhD

Blood (2012) 120 (21): 3726.

https://doi.org/10.1182/blood.V120.21.3726.3726

Published: 2012

Journal Articles

A Niche-Based Cell Mutagenesis Assay Identifies ABL-Kinase Mutations Appearing in BCR-ABL T315I-Mutated Leukemic Cells Treated with Ponatinib.

Djamel Aggoune, Nathalie Sorel, PhD, Marie Laure Bonnet, Jean-Claude Chomel, PharmD, PhD, Ali G Turhan, M.D., PhD

Blood (2012) 120 (21): 2436.

https://doi.org/10.1182/blood.V120.21.2436.2436

Published: 2012

Journal Articles

Molecular Characterization of the Leukemic Niche in Chronic Myeloid Leukemia (CML) and Evaluation of a Leukemia / Niche Cross-Talk

Djamel Aggoune, Nathalie Sorel, PhD, Sanaa El Marsafy, MD, PhD, Marie Laure Bonnet, Denis Clay, Marie Claude Meunier, Karin Tarte, Olivier Herault, MD, PhD, Jorge Domenech, MD, PhD, Agnès Guerci, MD, Jean-Claude Chomel, PharmD, PhD, Ali G Turhan, M.D., PhD

Blood (2012) 120 (21): 908.

https://doi.org/10.1182/blood.V120.21.908.908

Published: 2012

Journal Articles

T315I Mutation INCREASES the GENOMIC Instability and the Mutator Phenotype IN BCR-ABL-Expressing LEUKEMIC CELLS.

Djamel Aggoune, Angelina Bertrand, Marie Laure Bonnet, Amelie Le Corf, Sandrine Girerd, Fatima Dkhissi, PhD, Nathalie Sorel, PhD, Jean-Claude Chomel, PharmD, PhD, Annelise Bennaceur-Griscelli, MD, PhD, Ali G. Turhan, MD, PhD

Blood (2010) 116 (21): 3365.

https://doi.org/10.1182/blood.V116.21.3365.3365

Published: 2010

Journal Articles

Quantitative Monitoring of BCR-ABL mRNA Harboring the T315I Mutation in Chronic Myeloid Leukemia (CML).

Jean-Claude Chomel, PharmD, PhD, Nathalie Sorel, PhD, Francois Guilhot, MD, Ali G. Turhan, MD, PhD

Blood (2007) 110 (11): 2919.

https://doi.org/10.1182/blood.V110.11.2919.2919

Published: 2007

NARROW

Revisiting Early Stages of Chronic Myeloid Leukemia (CML): Evidence That Leukemic Progenitors Appear First in Peripheral Blood during Molecular Recurrence

Micro-RNA Profiling Reveals the Key Role of miR-206 in the Hematopoietic Potential of Human Embryonic and Induced Pluripotent Stem Cells

Prediction of One-Year Molecular Response to Imatinib at Diagnosis of Chronic Myeloid Leukemia By Scoring Gene Expression Levels of Antioxidant Enzymes

ETS1 Expression Is Upregulated in Chronic Myeloid Leukemia (CML) and the ETS1 Transcriptional Program Correlates with Disease Progression Towards Blast Crisis

The Cell Surface NADH Oxidase ENOX2 Is Highly Expressed in Chronic Myeloid Leukemia (CML): a Redox Protein As a Secreted Surrogate Biomarker and Druggable Target

Combination of Dasatinib and Peg-Interferon Alpha 2b in Chronic Phase Chronic Myeloid Leukemia (CP-CML) First Line: Preliminary Results of a Phase II Trial, from the French Intergroup of CML (Fi-LMC)

A Novel DNA Repair Chip Assay Allows Rapid Identification of DNA Repair Abnormalities Induced By BCR-ABL

Superoxide Dismutase 2 (Sod2) Expression Is Highly Decreased In Chronic Myeloid Leukemia (CML): Contribution To Genetic Instability In Bcr-Abl-Expressing Leukemic Cells

Interferon-Inducible Protein 16 (IFI-16) Is Upregulated In Chronic Myeloid Leukemia (CML) and Is Involved In Oncogene-Induced Senescence

BRCA1-Down-Regulation In Chronic Myeloid Leukemia (CML) Occurs Via The Deubiquitinase / Tumor Suppressor BRCA1-Associated Protein 1 (BAP1)

T315I-Mutated BCR-ABL Induces a Distinct and Specific Molecular Signature With High Expression Of Zinc Finger (ZNF) Transcription Factors

Sequential Measurement Of JAK2 V617F Allele Burden In Polycythemia Vera and Essential Thrombocythemia Reveals Different Evolution Profiles: First Results Of Jaksuivi, a Multicentre Study By The French Intergroup Of Myeloproliferative Neoplasms (FIM)

Evaluation of Leukemic Stem Cell Persistence in Chronic Myeloid Leukemia (CML) Patients in Complete Molecular Remission Induced by First Line TKI Therapies

A Niche-Based Cell Mutagenesis Assay Identifies ABL-Kinase Mutations Appearing in BCR-ABL T315I-Mutated Leukemic Cells Treated with Ponatinib.

Molecular Characterization of the Leukemic Niche in Chronic Myeloid Leukemia (CML) and Evaluation of a Leukemia / Niche Cross-Talk

T315I Mutation INCREASES the GENOMIC Instability and the Mutator Phenotype IN BCR-ABL-Expressing LEUKEMIC CELLS.

Quantitative Monitoring of BCR-ABL mRNA Harboring the T315I Mutation in Chronic Myeloid Leukemia (CML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only